Context Therapeutics Inc.
Context Therapeutics Inc. (CNTX) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 24 transactions totaling $295.3K, demonstrating a bullish sentiment with $295.3K in net insider flow. The most recent transaction on Feb 21, 2023 involved a purchase of 5,823 shares valued at $4.9K.
CNTX Insider Activity Summary
Who Is Buying CNTX Stock?
No significant insider buying has been recorded for CNTX in the recent period.
Who Is Selling CNTX Stock?
No significant insider selling has been recorded for CNTX in the recent period.
Is Context Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CNTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $295.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CNTX Frequently Asked Questions
Understanding CNTX Insider Activity
Insider trading at Context Therapeutics Inc. (CNTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading CNTX stock, having executed 24 transactions in the past 90 days. The most active insider is Martin A. Lehr (Executive), who has made 17 transactions totaling $962.5K.
Related Tools
Track Context Therapeutics Inc. Insider Activity
Get notified when executives and directors at CNTX file new Form 4 transactions